Literature DB >> 27817809

Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study.

Zarqa Ali1, Lisbeth Nilas2, Charlotte Suppli Ulrik3.   

Abstract

BACKGROUND: Asthma in pregnancy have been associated with an increased risk of pregnancy complications. Our aim was to estimate incidence and describe risk factors for adverse obstetrical and perinatal outcomes in pregnant women with asthma.
METHODS: Women enrolled in the Management of Asthma during Pregnancy (MAP) program were each matched with three controls (i.e. consecutive women giving birth at our obstetrical service). Asthma severity was classified according to treatment step. Data on obstetrical and perinatal outcomes were obtained from medical records. Logistic regression analysis was applied, and findings expressed as odds ratios (OR) unadjusted and adjusted (adj) for BMI, age, parity, smoking, ethnicity and marital status.
RESULTS: Nine-hundred-thirty-nine pregnancies in women with asthma (i.e. cases) were compared to 2.782 controls. Overall, the incidence of complications was low, although women with asthma had a statistically significant higher risk of pre-eclampsia (5% vs. 3%, ORadj 1.60, 95% CI 1.07-2.38; p = 0.02) and small for gestational age neonates (SGA) (ORadj 1.30, 95% CI 1.10-1.54; p < 0.01) compared to controls. Compared to mild asthma, more severe asthma was associated with a higher risk of SGA (60% vs 53%, ORadj. 1.30, 95% CI 1.10-1.54; p < 0.01). Women with asthma exacerbation during pregnancy tended to have a higher risk of severe pre-eclampsia (ORadj 3.33 95% CI 0.96-11.65, p = 0.06) compared to pregnancies without any exacerbations.
CONCLUSION: The overall risk of adverse obstetrical and perinatal outcomes in pregnancies complicated by asthma is low compared to non-asthmatic women. Our observations suggest that enrollment into an asthma management program has a positive impact on overall pregnancy outcome.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Case-control; Management program; Outcome; Pregnancy

Mesh:

Year:  2016        PMID: 27817809     DOI: 10.1016/j.rmed.2016.10.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Medicines prescribed for asthma, discontinuation and perinatal outcomes, including breastfeeding: A population cohort analysis.

Authors:  Gareth Davies; Sue Jordan; Daniel Thayer; David Tucker; Ioan Humphreys
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

Review 2.  Maternal asthma and gestational diabetes mellitus: Exploration of potential associations.

Authors:  M E Jensen; H L Barrett; M J Peek; P G Gibson; V E Murphy
Journal:  Obstet Med       Date:  2020-06-18

3.  Postpartum airway responsiveness and exacerbation of asthma during pregnancy - a pilot study.

Authors:  Zarqa Ali; Lisbeth Nilas; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2017-10-03

4.  Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study-The PRO-ART study protocol.

Authors:  Casper Tidemandsen; Elisabeth Juul Gade; Charlotte Suppli Ulrik; Henriette Svarre Nielsen; Birgitte Sophie Oxlund-Mariegaard; Karsten Kristiansen; Nina La Cour Freiesleben; Bugge Nøhr; Hanne Udengaard; Vibeke Backer
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.